Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.64%
|
$353,472
$32.81 P/Share
|
|
Apr 03
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
13,697
-100.0%
|
$479,395
$35.09 P/Share
|
|
Apr 03
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,697
+50.0%
|
$164,364
$12.21 P/Share
|
|
Apr 03
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-22.34%
|
$320,000
$32.81 P/Share
|
|
Apr 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,017
-0.06%
|
$300,510
$30.05 P/Share
|
|
Apr 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,339
-0.05%
|
$100,170
$30.05 P/Share
|
|
Mar 27
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.61%
|
$309,288
$28.37 P/Share
|
|
Mar 27
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-18.26%
|
$280,000
$28.37 P/Share
|
|
Mar 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$125,000
$25.81 P/Share
|
|
Mar 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$135,000
$27.76 P/Share
|
|
Mar 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
21,658
-0.57%
|
$628,082
$29.13 P/Share
|
|
Mar 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,537
-0.05%
|
$102,573
$29.13 P/Share
|
|
Mar 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-15.44%
|
$290,000
$29.13 P/Share
|
|
Mar 18
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
15,281
-73.21%
|
$473,711
$31.41 P/Share
|
|
Mar 18
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,281
+50.0%
|
$183,372
$12.21 P/Share
|
|
Mar 17
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
16,317
-83.25%
|
$505,827
$31.65 P/Share
|
|
Mar 17
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,317
+50.0%
|
$195,804
$12.21 P/Share
|
|
Mar 16
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.4%
|
$520,000
$26.17 P/Share
|
|
Mar 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
4,676
-0.07%
|
-
|
|
Mar 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.39%
|
$231,966
$21.52 P/Share
|
|
Mar 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-13.37%
|
$230,000
$23.0 P/Share
|
|
Mar 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
4,990
-0.06%
|
$104,790
$21.77 P/Share
|
|
Mar 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$115,000
$23.42 P/Share
|
|
Mar 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,351
-0.07%
|
$308,775
$25.71 P/Share
|
|
Mar 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,117
-0.06%
|
$102,925
$25.71 P/Share
|
|
Mar 09
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
104
-100.0%
|
$3,120
$30.0 P/Share
|
|
Mar 09
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104
+50.0%
|
$1,248
$12.21 P/Share
|
|
Mar 09
2020
|
Jennifer Ling Lee Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
361
-7.55%
|
$9,747
$27.33 P/Share
|
|
Mar 06
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.77%
|
$309,288
$28.77 P/Share
|
|
Mar 06
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.8%
|
$270,000
$27.98 P/Share
|
|
Mar 04
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.56%
|
$540,000
$27.71 P/Share
|
|
Mar 02
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
3,001
-100.0%
|
$90,030
$30.12 P/Share
|
|
Mar 02
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,001
+50.0%
|
$36,012
$12.21 P/Share
|
|
Mar 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,570
-0.07%
|
$312,390
$27.09 P/Share
|
|
Mar 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,857
-0.06%
|
$104,139
$27.09 P/Share
|
|
Feb 28
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-10.55%
|
$230,000
$23.38 P/Share
|
|
Feb 28
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.38%
|
$265,104
$24.07 P/Share
|
|
Feb 27
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
8,006
-62.25%
|
$264,198
$33.48 P/Share
|
|
Feb 27
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,006
+50.0%
|
$96,072
$12.21 P/Share
|
|
Feb 26
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,652
-0.48%
|
$522,256
$28.74 P/Share
|
|
Feb 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,286
-0.08%
|
$121,578
$23.0 P/Share
|
|
Feb 25
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,348
-0.05%
|
$33,700
$25.87 P/Share
|
|
Feb 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.48%
|
$180,000
$18.67 P/Share
|
|
Feb 21
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.54%
|
$180,000
$18.47 P/Share
|
|
Feb 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.49%
|
$198,828
$18.16 P/Share
|
|
Feb 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,286
-0.03%
|
$95,148
$18.86 P/Share
|
|
Feb 18
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
5,000
-0.07%
|
-
|
|
Feb 14
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.47%
|
$209,874
$19.02 P/Share
|
|
Feb 14
2020
|
Paul Sagan Director |
BUY
Open market or private purchase
|
Indirect |
52,631
+11.13%
|
$999,989
$19.0 P/Share
|
|
Feb 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.24%
|
$95,000
$19.23 P/Share
|